{
    "organizations": [],
    "uuid": "e41f46612fa679fca9fa74208e1242ef72bb9fda",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-novartis-ag-cfo-says-q2-core-opera/brief-novartis-ag-cfo-says-q2-core-operating-profit-growth-to-be-in-low-to-mid-single-digits-improvements-to-come-idUSFWN1RW0LN",
    "ord_in_thread": 0,
    "title": "BRIEF-Novartis AG CFO Says Q2 Core Operating Profit Growth To Be In Low To Mid Single Digits, Improvements To Come",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 19 (Reuters) - Novartis AG:\n* CFO SAYS Q2 CORE OPERATING PROFIT GROWTH TO BE IN LOW TO MID SINGLE DIGITS, FOLLOWED BY IMPROVEMENTS LATER IN YEAR\n* CEO SAYS TRUMP ADMINISTRATION HAS SHOWN HUGE INTEREST IN BIOSIMILARS Source text for Eikon: Further company coverage: (Reporting by John Miller)\n ",
    "published": "2018-04-19T21:22:00.000+03:00",
    "crawled": "2018-04-20T12:17:00.011+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "novartis",
        "ag",
        "cfo",
        "say",
        "q2",
        "core",
        "operating",
        "profit",
        "growth",
        "low",
        "mid",
        "single",
        "digit",
        "followed",
        "improvement",
        "later",
        "year",
        "ceo",
        "say",
        "trump",
        "administration",
        "shown",
        "huge",
        "interest",
        "biosimilars",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "reporting",
        "john",
        "miller"
    ]
}